Transsphenoidal surgery in acromegaly investigated by intraoperative high-field magnetic resonance imaging
- 1 August 2005
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Acta Endocrinologica
- Vol. 153 (2), 239-248
- https://doi.org/10.1530/eje.1.01970
Abstract
The aim of the study was to evaluate the effect of intraoperative high-field (1.5 Tesla) magnetic resonance imaging (MRI) on the results of transsphenoidal surgery of GH-secreting pituitary macroadenomas. Twenty-three acromegalic patients (mean tumor size, 25 +/- 12 mm; untreated preoperative GH, 4.2-159 microg/l; IGF-I, 349-1111 microg/l) were investigated by intraoperative high-field MRI. If intraoperative imaging depicted an accessible tumor remnant, resection was continued. In five patients intraoperative MRI led to further tumor removal, two of these met the consensus criteria for endocrine remission after 3 months. In two patients basal GH and oral glucose tolerance test (OGTT) were <2 microg/l, only IGF-I was slightly elevated, and in one patient GH was <5 microg/l and OGTT was 2 microg/l, with elevated IGF-I. Final intraoperative MRI showed no tumor remnants in 14 patients; eight of them met the consensus criteria for remission of acromegaly. In the patients with MRI showing incomplete removal (four suspect findings and five patients with intended partial removal) none was normalized. With regard to the patients with a tumor configuration in whom complete tumor removal was considered (n = 18), intraoperative MRI increased the rate of endocrine normalization from 33 to 44% applying the consensus criteria, and improved endocrine outcome to 'nearly normalization' in another 17%. With regard to preoperative GH levels and tumor size, intraoperative MRI can help to achieve endocrine remission in patients who are normally considered not to be curable. However, taking GH as the tumor marker, even intraoperative high-field MRI was not able to detect tumor remnants in every case.Keywords
This publication has 34 references indexed in Scilit:
- The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical ‘cure’Acta Endocrinologica, 2005
- Transsphenoidal Surgery for Acromegaly in Wales: Results Based on Stringent Criteria of RemissionJournal of Clinical Endocrinology & Metabolism, 2003
- Long‐term outcome and mortality after transsphenoidal adenomectomy for acromegalyClinical Endocrinology, 2003
- Guidelines for Acromegaly ManagementJournal of Clinical Endocrinology & Metabolism, 2002
- Frameless stereotaxy as an alternative to fluoroscopy for transsphenoidal surgery: use of the InstaTrak®-3000 and a novel headsetJournal of Clinical Neuroscience, 2002
- Surgical Management of GH-Secreting Pituitary Adenomas: An Outcome Study Using Modern Remission CriteriaJournal of Clinical Endocrinology & Metabolism, 2001
- Transsphenoidal Surgery for Acromegaly: Endocrinological Follow-up of 98 PatientsNeurosurgery, 2001
- Predictors of the Outcome of Surgical Treatment in Acromegaly and the Value of the Mean Growth Hormone Day Curve in Assessing Postoperative Disease ActivityJournal of Clinical Endocrinology & Metabolism, 2001
- Criteria for Cure of Acromegaly: A Consensus StatementJournal of Clinical Endocrinology & Metabolism, 2000
- Frameless Stereotaxy for Transsphenoidal SurgeryNeurosurgery, 1999